Page last updated: 2024-08-23

nitazoxanide and Parkinsonian Disorders

nitazoxanide has been researched along with Parkinsonian Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amireddy, N; Kalivendi, SV; Puttapaka, SN; Ravuri, HG; Thonda, S; Vinnakota, RL	1

Other Studies

1 other study(ies) available for nitazoxanide and Parkinsonian Disorders

Article	Year
The unintended mitochondrial uncoupling effects of the FDA-approved anti-helminth drug nitazoxanide mitigates experimental parkinsonism in mice. The Journal of biological chemistry, 2017, 09-22, Volume: 292, Issue:38 Topics: Adenosine Triphosphate; Animals; Apoptosis; Cell Line, Tumor; Cell Respiration; Drug Approval; Helminths; Humans; Male; Membrane Potential, Mitochondrial; Mice; Mitochondria; Neurons; Nitro Compounds; Parkinsonian Disorders; Rats; Reactive Oxygen Species; Thiazoles; United States; United States Food and Drug Administration	2017

Article

Year

The unintended mitochondrial uncoupling effects of the FDA-approved anti-helminth drug nitazoxanide mitigates experimental parkinsonism in mice.

The Journal of biological chemistry, 2017, 09-22, Volume: 292, Issue:38

Topics: Adenosine Triphosphate; Animals; Apoptosis; Cell Line, Tumor; Cell Respiration; Drug Approval; Helminths; Humans; Male; Membrane Potential, Mitochondrial; Mice; Mitochondria; Neurons; Nitro Compounds; Parkinsonian Disorders; Rats; Reactive Oxygen Species; Thiazoles; United States; United States Food and Drug Administration

2017